Beranda › Sistem Imun dan Gangguan
Uji klinis Sistem Imun dan Gangguan yang merekrut di AS
43 studi untuk Sistem Imun dan Gangguan merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC13 studi
- New York City, NY12 studi
- Philadelphia, PA10 studi
- Boston, MA10 studi
- Houston, TX9 studi
- Atlanta, GA9 studi
- Portland, OR9 studi
- Los Angeles, CA8 studi
- Cleveland, OH8 studi
- Chicago, IL8 studi
- Cedar Rapids, IA6 studi
- Milwaukee, WI6 studi
- Seattle, WA6 studi
- Nashville, TN5 studi
- Salt Lake City, UT5 studi
- Tampa, FL5 studi
- Baldwin Park, CA5 studi
- Durham, NC5 studi
- Dallas, TX4 studi
- Pittsburgh, PA4 studi
- Clifton, NJ4 studi
- St. Louis, MO4 studi
- Orlando, FL3 studi
- Denver, CO3 studi
- The Bronx, NY3 studi
- Louisville, KY3 studi
- Norfolk, VA3 studi
- Richmond, VA3 studi
- Buffalo, NY3 studi
- Indianapolis, IN3 studi
- Omaha, NE3 studi
- Cincinnati, OH3 studi
- San Diego, CA3 studi
- New Haven, CT3 studi
- Mountain View, CA3 studi
- Phoenix, AZ3 studi
- San Francisco, CA3 studi
- Greenville, NC3 studi
- Rochester, MN3 studi
- Columbus, OH3 studi
Berdasarkan negara bagian
- Arizona3 studi
- Arkansas3 studi
- California18 studi
- Colorado4 studi
- Connecticut3 studi
- Distrik Columbia3 studi
- Florida11 studi
- Georgia10 studi
- Illinois9 studi
- Indiana4 studi
- Iowa6 studi
- Kentucky4 studi
- Maryland13 studi
- Massachusetts10 studi
- Michigan4 studi
- Minnesota4 studi
- Missouri6 studi
- Nebraska3 studi
- New Jersey6 studi
- New York14 studi
- North Carolina7 studi
- Ohio9 studi
- Oregon9 studi
- Pennsylvania12 studi
- South Carolina3 studi
- Tennessee5 studi
- Texas14 studi
- Utah5 studi
- Virginia6 studi
- Washington7 studi
- Wisconsin6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07192471Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 120 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00006150Detection and Characterization of Infections and Infection Susceptibility
Menerima pesertaStudi observasional
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00404560Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 4 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT02579967Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 7 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01568697Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Menerima pesertaStudi observasional
Usia 1 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00001406Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Menerima pesertaFase 2
Usia 4 hingga 69 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04339777Genetic Analysis of Immune Disorders
Menerima pesertaStudi observasional
1 Day – 101 Years · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT00001467A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07541287Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 99 Years · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00794352A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Menerima pesertaFase 2
Usia 18 hingga 69 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07699380(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318PS-002 for the Treatment of IgA Nephropathy in Adults
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07182227A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07765888A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07075185Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05826535A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Menerima pesertaFase 1/2
Usia 35 hingga 70 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06575426Abatacept for the Treatment of Giant Cell Arteritis
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT04474847A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06858319Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07759115A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07037901Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.